Skip to main content
. Author manuscript; available in PMC: 2011 Apr 1.
Published in final edited form as: Breast Cancer Res Treat. 2010 Sep 29;126(3):749–761. doi: 10.1007/s10549-010-1174-7

Table 1.

Relationship of demographic, treatment, and tumor characteristics to the risk of dying

Alive (n=1193) BC-related (n=283) Non-BC related (n=435) BC-related death All-cause death

n % n % n % HR1 95% CI HR1 95% CI
Age at diagnosis2
45-54 109 (9.1) 31 (11.0) 7 (1.6) 1.00 (ref) 1.00 (ref)
55-64 417 (35.0) 93 (32.9) 69 (15.9) 0.76 (0.50-1.14) 1.07 (0.75-1.52)
65-74 532 (44.6) 123 (43.5) 236 (54.3) 1.02 (0.60-1.74) 2.04 (1.35-3.08)
75-79 135 (11.3) 36 (12.7) 123 (28.3) 1.14 (0.58-2.22) 3.38 (2.13-5.35)
Age at menopause
<45 250 (22.5) 70 (26.3) 115 (29.2) 1.00 (ref) 1.00 (ref)
45-49 356 (32.0) 84 (31.6) 115 (29.2) 1.02 (0.73-1.42) 0.89 (0.73-1.10)
50+ 507 (45.6) 112 (42.1) 164 (41.6) 0.97 (0.71-1.32) 0.79 (0.66-0.96)
 Missing 80 17 41
Family history
No 1st degree 868 (77.7) 199 (76.8) 322 (78.3) 1.00 (ref) 1.00 (ref)
1st degree 249 (22.3) 60 (23.2) 89 (21.7) 1.08 (0.80-1.45) 1.04 (0.86-1.26)
 Missing 76 24 24
Mammography3,4
No 110 (9.5) 68 (24.9) 77 (18.4) 1.00 (ref) 1.00 (ref)
Yes 1054 (90.5) 205 (75.1) 341 (81.6) 0.42 (0.32-0.56) 0.50 (0.42-0.60)
 Missing 29 10 17
Time since last mammogram4
None 59 (5.1) 48 (17.5) 48 (11.3) 1.00 (ref) 1.00 (ref)
<2 yrs 845 (72.3) 142 (51.6) 268 (63.1) 0.30 (0.22-0.42) 0.44 (0.35-0.55)
2 yrs 157 (13.4) 42 (15.3) 53 (12.5) 0.45 (0.30-0.68) 0.51 (0.38-0.67)
3+ yrs 107 (9.2) 43 (15.6) 56 (13.2) 0.59 (0.39-0.90) 0.73 (0.55-0.96)
 Missing 25 8 10
Stage
Local 950 (79.9) 95 (34.1) 331 (77.3) 1.00 (ref) 1.00 (ref)
Regional/Distant 239 (20.1) 184 (65.9) 97 (22.7) 5.69 (4.41-7.35) 2.23 (1.91-2.61)
 Missing 4 4 7
Histology
Ductal 830 (69.6) 196 (69.3) 290 (66.7) 1.00 (ref) 1.00 (ref)
Any Lobular5 200 (16.8) 60 (21.2) 87 (20.0) 1.21 (0.90-1.63) 1.10 (0.91-1.33)
Other 163 (13.7) 27 (9.5) 58 (13.3) 0.72 (0.48-1.10) 0.94 (0.74-1.19)
ER status
ER+ 995 (83.4) 208 (73.5) 371 (85.3) 1.00 (ref) 1.00 (ref)
ER- 132 (11.1) 61 (21.6) 49 (11.3) 2.09 (1.55-2.82) 1.70 (1.38-2.10)
Borderline/Unknown 66 (5.5) 14 (4.9) 15 (3.4) 1.10 (0.64-1.89) 0.87 (0.59-1.27)
PR status
PR+ 904 (75.8) 175 (61.8) 322 (74.0) 1.00 (ref) 1.00 (ref)
PR- 226 (18.9) 94 (33.2) 98 (22.5) 1.91 (1.48-2.48) 1.58 (1.33-1.88)
Borderline/Unknown 63 (5.3) 14 (4.9) 15 (3.4) 1.24 (0.72-2.15) 0.93 (0.63-1.37)
Grade
Well 248 (23.7) 15 (6.2) 83 (21.8) 1.00 (ref) 1.00 (ref)
Moderate 446 (42.6) 72 (29.6) 158 (41.6) 2.35 (1.35-4.11) 1.25 (0.98-1.59)
Poor 302 (28.8) 129 (53.1) 121 (31.8) 5.42 (3.16-9.31) 1.98 (1.56-2.52)
Undifferentiated 51 (4.9) 27 (11.1) 18 (4.7) 6.49 (3.41-12.34) 2.10 (1.46-3.02)
 Missing 146 40 55
Tumor size
<1 cm 330 (28.2) 21 (8.3) 112 (26.5) 1.00 (ref) 1.00 (ref)
1-<2 cm 545 (46.6) 55 (21.7) 180 (42.6) 1.47 (0.88-2.44) 1.09 (0.88-1.35)
2+ cm 294 (25.1) 178 (70.1) 131 (31.0) 7.17 (4.54-11.31) 2.19 (1.78-2.69)
 Missing 24 29 12
1

Models adjusted for age (continuous), study, and mammography history, except where noted

2

Models not adjusted for age

3

History of mammography in the 5 years prior to diagnosis

4

Models not adjusted for mammography history

5

Lobular includes mixed lobular